Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting
Launched by ZHUJIANG HOSPITAL · Dec 6, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the P1, which is designed to quickly measure electrolytes—important minerals in the body that help with various functions, especially in emergency situations. The goal is to see how well the P1 device works compared to an established device called the Nova Stat Profile pHOx Ultra Analyzer. Researchers will look at how consistent the results are between the two devices when measuring electrolytes in patients who are being treated in the emergency department. They will also check for abnormal levels of magnesium, which can be important for heart and muscle function.
To participate in the trial, patients aged 28 and older who are scheduled to have electrolyte testing in the emergency department or intensive care unit may be eligible. However, those with certain infectious diseases or other specific conditions might not be included. If someone joins the study, they can expect to have their electrolyte levels measured using both the P1 and Nova devices at the same time during their emergency care. This research could help determine if the P1 device can be a helpful alternative for quick electrolyte testing in emergencies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are scheduled to undergo electrolyte measuring in the emergency department (ED) or emergency intensive care unit (ICU).
- Exclusion Criteria:
- • Patients with a confirmed history of infectious diseases such as hepatitis B, syphilis, HIV/AIDS, etc.
- • Missing residual sample types (serum or whole blood).
- • Patients whose residual blood samples are not tested within the specified time frame after collection.
- • Other patients deemed ineligible by the investigator.
About Zhujiang Hospital
Zhujiang Hospital, affiliated with the Southern Medical University in Guangzhou, China, is a leading clinical research institution dedicated to advancing medical science and improving patient care through rigorous clinical trials. With a strong commitment to ethical standards and patient safety, the hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals. Its state-of-the-art facilities enable the execution of innovative studies across various therapeutic areas, contributing valuable insights to the global medical community. Zhujiang Hospital aims to foster collaboration with academic institutions, pharmaceutical companies, and regulatory bodies to ensure the successful development of new therapies and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Hua Xie
Principal Investigator
Zhujiang Hospital, Southern Medical University Organization
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported